Quick Overview: Jeff Liter, MBA, Luminary Therapeutics, Minneapolis, MN, provides his Jeff Liter, MBA, Luminary Therapeutics, Minneapolis, MN, discusses the development of Kanya Rajangam, MD, PhD, NKarta Therapeutics, South San Francisco, CA, discusses the benefits of developing
Allogeneic Therapy Highlights At Advanced - Detailed Overview & Context
Jeff Liter, MBA, Luminary Therapeutics, Minneapolis, MN, provides his Jeff Liter, MBA, Luminary Therapeutics, Minneapolis, MN, discusses the development of Kanya Rajangam, MD, PhD, NKarta Therapeutics, South San Francisco, CA, discusses the benefits of developing Julia Tarasenko, MSc, Marken, Durham, NC, discusses changes that are needed in the supply chain to adapt to an increasing ... In this segment of Cell & Gene Live, Building the Future of Cancer Immunotherapy Through Tuna Mutis, MD, PhD, Amsterdam University Medical Center, Amsterdam, The Netherlands, discusses the advantages of using ...
Sven Kili, MD, Antion Biosciences SA, Geneva, Switzerland, provides an overview of the current landscape of autologous and ... Sven Kili, MD, Antion Biosciences SA, Geneva, Switzerland, describes the miCAR gene construct, a novel multiplex cell ... Elena Morozova, MD, PhD, RM Gorbacheva Research Institute, Pavlov University, St. Petersburg, Russian Federation, discusses ... In this In Focus feature, PromoCell has partnered with us to share their expertise on An excerpt from Cell & Gene Live's How To Reduce Batch-to-Batch Variation In Cell Christian Chabannon, MD, PhD, Paoli-Calmettes Institute, Marseille, France, outlines the key topics that will be discussed at the ...
Karlo Perica, MD, PhD, Memorial Sloan Kettering Cancer Center, New York, NY, outlines early evidence demonstrating the ... Orca Bio's CMO, Dr. Scott McClellan, joins Erin Harris on this episode of Cell & Gene: The Podcast to discuss how and why ...
